AKT1 and neoplasm: Given that PI3K/Akt and JAK/STAT3 signaling pathways engaged in PTC tumor stromal-cell-enhanced CSC aggressive behaviors in vitro, we investigated whether these signaling pathways were relevant to PTC tumorigenesis and tumor progression.